http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5243036-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8540619111951100462f864d7738579a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-795
filingDate 1991-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7ab0eac99afbf115f76d5280afa7fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9df811e5c3eb9538589fb86555d352a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c531125077184f5403661c11e08b124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0ec2f8ce45c63d6b6e986c284004e90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ef673630ccb10a01c518d53212971c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d7e87e648acf3f1f260752ba7f8198
publicationDate 1993-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5243036-A
titleOfInvention Process for obtaining polymers with antiviral activity
abstract The present invention consists in a process for obtaining polymers with antiviral activity which is characterised in that in water or in mixtures of water with water-miscible solvents, ruder specific conditions of temperature, time, and pH, molecules carrying carbonyl groups and hydroxyl groups in alpha position relative to the carbonyl, such as monosaccharides, react with molecules carrying amino and sulfonated groups, such as aliphatic amino-sulfonates; in that after the reaction ends, the polymeric material is purified by conventional processes, such that its molecular weight is within the range from 1,500 to 100,000; in that this polymeric material has antiviral activity and either lacks or presents very low toxicity and anticoagulant activity, and is thus suitable for production of pharmaceutical preparations suitable for use in topical or systemic antiviral therapy in humans or in animals. It is applicable in the pharmaceutical industry.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130655-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007184013-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007185216-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9629361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8119115-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8450378-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9283198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007135525-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009018213-A1
priorityDate 1990-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4681876-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4705777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4751077-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129716300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129747382

Total number of triples: 46.